Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Rights, Outstanding at beginning of period	324
Number of Rights, Exercised	(41)
Number of Rights, Granted	185	94
Number of Rights, Forfeited	(1)
Number of Rights, Outstanding at end of period	467
Number of Rights, Exercisable and vested at end of period	167
Number of Rights, Vested and expected to vest at end of period	455
Weighted Average Exercise Price, Outstanding at beginning of period	$ 53.98
Weighted Average Exercise Price, Exercised	$ 51.10
Weighted Average Exercise Price, Granted	$ 68.12
Weighted Average Exercise Price, Forfeited	$ 58.79
Weighted Average Exercise Price, Outstanding at end of period	$ 59.82
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 51.71
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 59.71
Weighted Average Remaining Contractual Life, Outstanding at end of period	3 years 8 months 16 days
Weighted Average Remaining Contractual Life, Exercisable and vested at end of period	2 years 6 months 29 days
Weighted Average Remaining Contractual Life, Vested and expected to vest at end of period	3 years 8 months 9 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 3,403
Aggregate Intrinsic Value, Exercisable and vested at end of period	2,459
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 3,371